GE HealthCare Stock - analyst consensus and earnings outlook
Published on 06/22/2026 at 07:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Edited by ad hoc news Earnings & Calendar Desk. Verified prior to publication on 06/22/2026, 07:53 CET. Details in the imprint.
GE HealthCare (US36266G1076) sits in the medical technology spotlight as investors look ahead to the company’s next quarterly earnings release and how it will track against current Wall Street expectations. Analyst estimates frame the debate around revenue, margin and cash flow trends in its imaging-led portfolio.
All news and analysis on GE HealthCare stock
Key figures, estimates and filings on GE HealthCare stock are bundled here for readers who want to follow the company beyond today’s consensus snapshot.
What consensus estimates show
GE HealthCare, which trades on Nasdaq under the ticker GEHC, last reported its quarterly numbers on 04/30/2024 for the first quarter, posting revenue of around $4.65 billion and adjusted earnings that modestly exceeded analyst expectations according to public earnings summaries.
For the coming quarters, market data aggregators show Wall Street expecting mid-single-digit revenue growth for the full year and a gradual improvement in operating margins as the company works through productivity and pricing measures in its core imaging and ultrasound franchises.
How analysts rate the stock
Across major brokerages that cover GE HealthCare, the current rating mix clusters around neutral to moderately positive, with a majority of firms maintaining Hold or Buy recommendations and only a small minority on the Sell side, based on consensus overview pages from financial data providers.
Average 12-month price targets compiled by these services sit modestly above the recent share price, indicating that analysts see some upside potential but are broadly cautious about valuation after the stock’s spin-off re-rating and the capital intensity of diagnostics equipment.
What the company sells
GE HealthCare generates its revenue primarily from medical imaging systems such as magnetic resonance imaging scanners, computed tomography scanners and ultrasound devices, alongside related software, contrast agents and service contracts that support hospitals and clinics worldwide.
Where the stock trades today
The shares of GE HealthCare (US36266G1076) trade on Nasdaq at $61.59 as of 06/18/2026, 16:00 ET.
Key facts on GE HealthCare stock
- Company: GE Healthcare Technologies Inc.
- ISIN: US36266G1076
- WKN: A3D3GE
- Ticker: GEHC
- Venue: Nasdaq
- Price (as of 06/18/2026, 16:00 ET): 61.59 USD
- Market cap: 28.02 billion USD (as of 06/18/2026)
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: Standard & Poor's 500 index
- Next earnings date: not officially scheduled
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
